Dr. Francis Lee, a psychiatrist and scientist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, has received a commendation by the president of the United States in the form of a Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the White House Office of Science and Technology Policy for outstanding (more…)
Consumer Health
Sciences, a leading international provider of comprehensive consumer
health information and patient reported outcomes, presented important
data at the ISPOR 11th Annual European Congress, Athens, Greece,
November 11, 2008. Findings demonstrated high unmet needs among
patients with depression using SSRIs or SNRIs.
Selective serotonin reuptake inhibitors (SSRIs) and
serotonin-norepinephrine (more…)
Valdoxan® today received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for its use in the treatment of adult patients with Major Depressive Episodes (MDE).1
Valdoxan is an innovative approach to the treatment of MDE and has demonstrated convincing efficacy in depressed patients with moderate-severe depression2, offering new hope (more…)
There are few studies comparing the efficacy of short-term psychodynamic psychotherapy (STPP) and pharmacotherapy in major depressive disorder. A group of finnish investigators conducted a comparative study on the efficacy of STPP versus fluoxetine treatment in patients with major depressive disorder in a primary care setting.
Fifty-one (more…)
SAN FRANCISCO, CA, USA (UroToday.com) - The authors previously reported an effect of antidepressants on semen parameters. The current study was designed to assess/confirm their prior report of the effects of an SSRI, paroxetine (Paxil), on semen parameters.
This (more…)
Antidepressants are the cornerstone of treatment of depressive disorders in health care. Their efficacy in treating depression is undisputable, although it leaves room for improvement. However, recent reports also suggest that antidepressants might, in some rare cases, actually worsen suicidal tendencies instead of alleviating them. As a consequence, (more…)
CNS Response, Inc.
(OTCBB: CNSO) reported today the results of a study presented at the
U.S. Psychiatric and Mental Health Congress by Daniel Hoffman, M.D.,
Chief Medical Officer for CNS Response. The poster presentation,
titled "First Do No Harm: Children and SSRIs," provided an analysis
of the utilization of SSRIs (Selective Serotonin Reuptake Inhibitors)
as a first-line treatment in children or adolescents without the
benefit (more…)
Women who took the antidepressant fluoxetine during the first three months of
pregnancy gave birth to four times as many babies with heart problems as women
who did not and the levels were three times higher in women taking paroxetine.
Although some of the conditions were serious, others were not severe and (more…)
Buy ultram without prescription Recent media coverage has questioned the prescription and safety of a class of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs) in children and adolescents.
"General practitioners are a critical part of the mental health care system in Australia and are often the first point (more…)
Patients suffering from major depression are at an increased risk for cardiovascular disease, but treating these patients with medication can greatly reduce the risk, according to new findings by researchers at the (more…)
Powered by WordPress